News

17 Feb: Accel-Rx/BDC make second portfolio investment in ScarX Therapeutics

Company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence for the Commercialization of Research (CECR), and its partner BDC Capital today announced their second joint investment in ScarX Therapeutics, a Canadian biotechnology…

13 Jan: GE Healthcare, FedDev Ontario Commit CAD $40M for New CCRM – Led Centre to Solve Cell Therapy Manufacturing Challenges

New centre for advanced therapeutic cell technologies will accelerate development andaccessibility of cell manufacturing technologies Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building…

11 Jan: Ministers of International Trade and Small Business and Tourism announce new export program for Canadian companies

January 5, 2016 – Kitchener, Ontario – Global Affairs Canada The Honourable Chrystia Freeland, Minister of International Trade, and the Honourable Bardish Chagger, Minister of Small Business and Tourism, today announced CanExport, a new program that will provide $50 million to help Canadian small and medium-sized enterprises take advantage of global…

14 Oct: Life Sciences Ontario Statement on MaRS

TORONTO, ON – (October 22, 2014) – Recent media attention around the MaRS Discovery District (MaRS) has focused on the refinancing of Phase II of their development. Lost in this discussion is the importance of MaRS as an incubator facilitating the commercialization of research into technologies that will have significant…